Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Publication Date timeline is not available.
Page 1
Improved survival with enasidenib versus standard of care in relapsed/refractory acute myeloid leukemia associated with IDH2 mutations using historical data and propensity score matching analysis.
Cancer Med. 2021 Sep;10(18):6336-6343. doi: 10.1002/cam4.4182. Epub 2021 Aug 24.
Cancer Med. 2021.
PMID: 34427990
Free PMC article.
Oral azacitidine preserves favorable level of fatigue and health-related quality of life for patients with acute myeloid leukemia in remission: results from the phase 3, placebo-controlled QUAZAR AML-001 trial.
Roboz GJ, Döhner H, Pocock C, Dombret H, Ravandi F, Jang JH, Selleslag D, Mayer J, Martens UM, Liesveld J, Bernal T, Wang MC, Yu P, Shi L, Guo S, La Torre I, Skikne B, Dong Q, Braverman J, Nehme SA, Beach CL, Wei AH.
Roboz GJ, et al. Among authors: nehme sa.
Haematologica. 2021 Dec 1;106(12):3240-3244. doi: 10.3324/haematol.2021.279174.
Haematologica. 2021.
PMID: 34551506
Free PMC article.
Clinical Trial.
No abstract available.
Item in Clipboard
A systematic literature review of disease burden and clinical efficacy for patients with relapsed or refractory acute myeloid leukemia.
Oliva EN, Ronnebaum SM, Zaidi O, Patel DA, Nehme SA, Chen C, Almeida AM.
Oliva EN, et al. Among authors: nehme sa.
Am J Blood Res. 2021 Aug 15;11(4):325-360. eCollection 2021.
Am J Blood Res. 2021.
PMID: 34540343
Free PMC article.
Review.
Item in Clipboard
Cite
Cite
ARTICLE TYPE
ARTICLE LANGUAGE
AGE
Filters on the sidebar will be reset to the default list and any currently applied filters will be cleared.